The debate over intelligence/" class="gmj-dict-autolink" title="Dictionary: Artificial Intelligence">artificial intelligence regulation in healthcare is focusing on the wrong target. Instead of purely technical certification frameworks, the medical profession must establish physician-led licensure systems that place clinical accountability at the centre of AI deployment in patient care. This argument, advanced by researchers in STAT News, challenges regulators and professional bodies to rethink how AI tools enter clinical practice.
Key takeaways
- Current AI regulatory frameworks prioritise technical validation over clinical accountability
- Physicians must lead licensure decisions to ensure patient safety and professional responsibility
- Technology standards alone cannot protect patients from inappropriate clinical deployment
- The medical profession needs new governance models that integrate AI oversight with existing licensure structures
Current AI Regulation Gaps in Healthcare
Where clinical accountability is missing from existing frameworks
Source: AI governance analysis | Georgian Medical Journal News
The Accountability Gap in AI Regulation
Most current AI regulation in healthcare focuses on algorithmic accuracy, data security, and technical performance metrics. However, this approach overlooks a fundamental principle: physicians bear professional and legal responsibility for all treatment decisions involving their patients, including those informed by AI tools. According to commentary in STAT News by Afnan R. Tariq and Ami Bhatt, this disconnect creates a governance vacuum where technology enters clinical practice without corresponding clinical oversight.
The distinction matters profoundly. A tool may pass all technical validation benchmarks yet be clinically inappropriate for a given patient population or context. Clinical updates frameworks increasingly show that physician judgment about deployment context—patient comorbidities, local practice patterns, resource constraints—cannot be automated. Regulators have traditionally certified medications and devices through pathways that require demonstrating not just technical efficacy but clinical safety in real-world settings. AI tools deserve the same rigour.
Physicians who answer for patient outcomes must lead the way AI enters patient care, not as an afterthought to technical approval but as a core component of licensure governance.
— Afnan R. Tariq and Ami Bhatt, STAT News (2026)
Why Physician-Led Licensure Matters
Professional licensure systems have long served as a mechanism to ensure that practitioners possess not only knowledge but judgment about appropriate care delivery. When physicians license an AI tool for their institution or practice, they assume professional responsibility for its clinical deployment. This creates aligned incentives: the clinician’s reputation and liability interest directly connect to ensuring appropriate use.
Physician-led oversight also accommodates clinical context that regulators cannot prescribe. A diagnostic AI may be appropriate in a tertiary centre with radiologist expertise but dangerous in a resource-limited setting where clinicians lack the training to interpret or challenge algorithmic recommendations. Health policy frameworks in countries like Canada and parts of Europe are beginning to adopt this model, requiring institutional medical staff approval before AI deployment. This mirrors existing credentialing processes for new surgical techniques or medications used off-label.
The governance model also creates enforceable accountability. If a physician licenses an AI tool and adverse outcomes result from misuse or inappropriate deployment, there is a clear chain of responsibility. Current technical-only frameworks often leave patients with limited recourse when AI failures occur in clinical settings.
Building Accountability Into AI Governance
Implementing physician-led licensure requires structural changes to medical regulation. Professional bodies must develop transparent criteria for which AI tools warrant institutional approval and which safety monitoring systems must accompany deployment. This is not bureaucratic obstruction but clinical due diligence.
Several models are emerging. Some regulatory jurisdictions are requiring that institutions establish quality and safety committees that review AI tools before clinical use, similar to drug and device approval processes. Others are developing AI credentialing pathways for individual physicians, certifying competence in using specific algorithms in specific clinical contexts. All effective models centre physician judgment, not just technical validation.
This approach is compatible with innovation. Physician-led review can accelerate appropriate deployment while preventing misuse. It also creates feedback loops: clinicians observing real-world performance can report back to developers and regulators, improving both technology and governance iteratively.
What This Means
What this means
Frequently asked questions
How would physician licensure of AI tools work in practice?
Institutions would establish AI review committees—similar to existing drug and device committees—comprising clinical specialists, informaticists, and quality officers. Before deploying a clinical AI tool, this committee would assess its accuracy, clinical appropriateness for the institution’s patient population, necessary safeguards, and monitoring protocols. Physicians would formally approve use, assuming professional responsibility for deployment. This process would be periodic, not one-time, as clinical evidence and tool performance accumulate.
Wouldn’t physician licensure slow AI innovation in healthcare?
Structured review need not delay appropriate deployment. Many jurisdictions have demonstrated that institutional review accelerates safe innovation: tools identified as genuinely valuable move quickly through approval, while those with limited clinical benefit are appropriately restricted. The current situation—where some AI tools deploy without clinical oversight while others face indefinite regulatory limbo—may actually be slower overall.
What is the difference between physician licensure of AI and existing medical device regulation?
Device regulation certifies that a product meets technical standards; physician licensure adds a clinical layer, ensuring that a technically sound tool is appropriate for a specific clinical context and population. Both are necessary. Device regulators cannot know every local practice pattern, resource constraint, or patient demographic. Physician-led oversight adapts technical validation to clinical reality.
As AI tools proliferate in medicine, healthcare systems face a critical choice: regulate technology alone, or embed clinical accountability into governance. The evidence increasingly suggests that physician-led licensure—not as an alternative to technical validation but as a complement—offers the most defensible path to safe innovation. The physicians who answer for patient outcomes must have decision-making power over how AI enters clinical practice.
Source: Opinion: The AI licensure debate is missing the point of licensure, STAT News
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
